Biaggioni really looks interesting. I had no idea he was looking at Rituximab as well - perhaps a hot item for CFS.
Now for the bad news! Pat Sonnett informed me that that wonderful panel only had 7 grants to review! - a number Dr Klimas called 'pitiful'.

They only meet three or four times a year.....probably three - that's 21 grants attempted a year - they've got to do better!
That is the other half of the equation; CFS researchers have to apply as well.....Hopefully Dr. Freidberg has spread the word in at the IACFS/ME that the panel is open for business.